Michael S. Perkinton

Author

Also Known As

M. Perkinton, M.S. Perkinton, Michael Perkinton, Michael S Perkinton, Michael S. Perkinton, Michael S. Perkinton, Perkinton, Michael

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

King's College London AstraZeneca (United Kingdom)University College London Trinity College Dublin Brigham and Women's Hospital

About

Michael S. Perkinton is an author at King's College London specializing in medicine, neuroscience, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	631
2	Cell Biology	7	7	505
3	Social Sciences	6	6	329
4	Biochemistry	1	1	70
5	Cellular Physiology	1	1	19

Michael S. Perkinton

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Phosphatidylinositol 3‐kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones Michael S. Perkinton, James E. Ip, Gemma L. Wood, Journal of Neurochemistry	2002	209
Ca<sup>2+</sup>-Permeable AMPA Receptors Induce Phosphorylation of cAMP Response Element-Binding Protein through a Phosphatidylinositol 3-Kinase-Dependent Stimulation of the Mitogen-Activated Protein Kinase Signaling Cascade in Neurons Michael S. Perkinton, Talvinder S. Sihra, Robert J. Williams Journal of Neuroscience	1999	197
Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways Lewis Evans, Thomas Wassmer, Graham Fraser, Cell Reports Neurodegenerative DiseasesSignal TransductionDistinct PathwaysDegenerative PathologyNeurotransmission	2018	190
Synaptic NMDA Receptor Activation Stimulates α-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-β Production Sarah E. Hoey, Robert J. Williams, Michael S. Perkinton Journal of Neuroscience	2009	174
PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins Grant T. Corbett, Zemin Wang, Wei Hong, Acta Neuropathologica	2019	158
Learnings about the complexity of extracellular tau aid development of a blood‐based screen for Alzheimer's disease Zhicheng Chen, David Mengel, Ashvini Keshavan, Alzheimer s & Dementia	2018	118
Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau<i>In Vivo</i> Tomáš Ondrejčák, Igor Klyubin, Grant T. Corbett, Journal of Neuroscience	2018	115
p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis Steven Ackerley, Andrew J. Grierson, Steven J. Banner, Molecular and Cellular Neuroscience Neurodegenerative DiseasesAmyotrophic Lateral SclerosisMolecular NeuroscienceMedicineNeurofilament Pathology	2004	112
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo Darren J. Schofield, Lorraine Irving, Laura Calò, Neurobiology of Disease	2019	110
The ‘glial’ glutamate transporter, EAAT2 (Glt‐1) accounts for high affinity glutamate uptake into adult rodent nerve endings Sachin K. Suchak, Nicoletta V. Baloyianni, Michael S. Perkinton, Journal of Neurochemistry	2003	107

Page 1